WO2006035508A1 - アトピー性皮膚炎を軽減または予防する物品 - Google Patents
アトピー性皮膚炎を軽減または予防する物品 Download PDFInfo
- Publication number
- WO2006035508A1 WO2006035508A1 PCT/JP2004/014542 JP2004014542W WO2006035508A1 WO 2006035508 A1 WO2006035508 A1 WO 2006035508A1 JP 2004014542 W JP2004014542 W JP 2004014542W WO 2006035508 A1 WO2006035508 A1 WO 2006035508A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- atopic dermatitis
- fiber
- cationized
- sweat
- article
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
Definitions
- the present invention relates to an article for removing a causative substance of atopic dermatitis. More specifically, the present invention relates to an outer skin application article that reduces or prevents inflammation and itching (hereinafter referred to as symptoms) in atopic dermatitis by removing a causative agent of atopic dermatitis.
- Atopic dermatitis is a Fatty disease caused by the addition of various environmental factors to the genetic factors that are likely to produce IgE antibodies against normal antigens. It develops from infancy and becomes chronic with age. Most of the cases improve before puberty, but some cases continue after puberty and some cases develop after puberty. Most adult cases are particularly intractable, and subsequent remission with aging is difficult to expect.
- Non-patent Document 1 Non-patent Document 2
- Patent Document 2 JP 2003-105674 A (Method for producing antibacterial fiber product and antibacterial agent composition for fiber)
- Patent Document 3 2001-303372 (antibacterial and antiviral acrylonitrile fiber and its production method)
- Patent Document 4 Japanese Patent Application Laid-Open No. 2001-278716 (Antimicrobial agent for fiber and antibacterial fiber product)
- Patent Document 5 Japanese Patent Application Laid-Open No. 9-228243 (Antimicrobial fiber material)
- Patent Document 6 Japanese Patent Laid-Open No. 2003-64101 (Method for Producing Cationic Starch)
- Patent Document 7 Japanese Patent Laid-Open No. 2001-64883 (Method of Spreading Pigment on Silk Fiber)
- Patent Document 8 Japanese Patent Laid-Open No. 7-316988 No. (Dyeing method of cellulosic fiber fabric and cellulosic fiber fabric dyed by the method)
- Non-Patent Document 1 Masaaki Uehara, Zentaka Furue, Yoshiki Miyaji. Atopic Dermatitis. Latest Dermatology University of Science 3, Eczema ⁇ Eczema ⁇ Pruritus ⁇ Erythema ⁇ Urticaria, Nakayama Shoten, 2002, pp37- 57
- Non-patent document 2 Masutaka Furue, Fukumi Fukumi, Michihiro Hide, Kazuhiko Takehara: Full text correction: Japanese Dermatological Association Atopic Dermatitis Treatment Guidelines 2003 Revised Edition, Japanese Dermatological Association Journal 113: 451-457, 2003
- an article for reducing or preventing atopic dermatitis is provided by removing the causative substance.
- the article of the present invention is preferably a natural fiber or regenerated fiber; a polysaccharide, a hydrolyzate or oligosaccharide thereof; a chemical product; or a water-absorbing polymer. More specifically, the article of the present invention is clothes, sanitary products, medical materials, external preparations, quasi-drugs, cosmetics, etc. that come into contact with, apply to, or adhere to a human skin.
- the present invention is based on a completely new idea of alleviating symptoms by selectively adsorbing substances causing atopic dermatitis contained in sweat, such as sweat antigens, to a cationic product.
- the sweat antigen secreted on the body surface is Since it is adsorbed by these substances and does not enter the dermis again, it does not cause an allergic reaction even though it is an antigenic substance on the skin surface.
- FIG. 1 shows the results of measuring the residual hysamine release activity after treating human sweat with a column filled with cationized fibers.
- Figure 2 shows the results of measuring the amount of protein after treating human sweat with a column filled with cationized fibers.
- Figure 3 shows the results of measuring the residual histamine release activity after reacting arbor sweat with cationized fibers in a test tube.
- Figure 4 shows the results of measuring protein concentration after reacting human sweat with cationized fibers in a test tube.
- a material having a hydroxyl group, an amino group, a carboxyl group or the like capable of introducing a cationic group in the molecule, which does not penetrate into the skin tissue.
- natural fibers such as cotton, silk, hemp, wool, collagen, etc.
- polysaccharides such as cellulose, agar, mannan, chitin, inulin, agar, starch, mucopolysaccharide or hydrolysates thereof (Hereinafter abbreviated as polysaccharides), oligosaccharides such as fructooligosaccharides, soybean oligosaccharides, galactooligosaccharides, xylo-oligosaccharides, lacto-oligosaccharides, raffinose, and tre-Laose, rayon, nitrocellulose, viscose lane, cuvula, PET bottle regenerated fiber, etc.
- polysaccharides such as cellulose, agar, mannan, chitin, inulin, agar, starch, mucopolysaccharide or hydrolysates thereof (Hereinafter abbreviated as polysaccharides), oligosacc
- Semi-synthetic fiber such as recycled fiber, acetate, triacetate, promix Polyester, Nylon, Acrylic, Polyurethane, Polyethylene, Vinylon and other plastics or synthetic fibers, Dendun-polyacrylonitrile hydrolyzate, Starch-Polyacrylate cross-linked product, Carboxymethyl cellulose, Vinyl acetate-Methyl acrylate copolymer And water-absorbing polymers such as sodium acrylate cross-linked products, and composite materials composed of two or more of these materials.
- cationic group such as ammonium derivatives, iminium derivatives, diazonium derivatives, acyclic nitrogen skeleton cations, nitrogen-containing cyclic skeleton cations, etc.
- the cationic group is an ammonium derivative. More preferably, it is a quaternary ammonium salt.
- common cationizing agents such as 2,3-epoxypropyltrimethylammonium chloride, 3-chloro-2-hydroxypropyl trimethyla Nyumumum chloride, etc. Sakamoto Yakuhin Kogyo Co., Ltd. “SY-GTA 80 J”, On the other hand, “Osaka Fats Co., Ltd.” “Cathionon U:”, Nagase ChemteX Co., Ltd.
- incorporación of a cationic group into the material can be achieved by adding the material and a cationizing agent to an alkaline aqueous solution such as sodium hydroxide and treating the material with 80 to 100 minutes for 30 to 60 minutes.
- a cationizing agent a mixture of 50 g / L of Cationone—UK (—Yoyu Yushi Co., Ltd.) and 15 g / L of sodium hydroxide aqueous solution, 10 kg, cotton cotton, 1 kg Is used under the condition of a bath ratio of 1:10 and reacted at 85 for 45 minutes.
- the material of the above-mentioned cationized article is a fibrous material such as natural fiber, regenerated fiber, semi-synthetic fiber or synthetic fiber, it can be made into fiber products such as yarn, woven fabric, knitted fabric, non-woven fabric, and braid. .
- a cationized fiber product using natural fibers such as cotton, silk, hemp, wool and collagen.
- Cationized fiber products can be used for clothes, underwear, sheets, evening ol, gauze, bandages, masks, fixing pandas, sanitary products, paper omuts, etc. that have the ability to reduce symptoms.
- a cationized water-absorbing polymer or a combination of a cationized article and a water-absorbing polymer is effective for sanitary products having a function of reducing symptoms, paper stuff, and the like.
- the cationized polysaccharide or the cationized oligosaccharide can be used as a paper napkin, tissue, or the like by sprinkling these or combining with the raw material of the paper.
- a cationized polysaccharide such as a cell mouth, agar, mannan, chitin, inulin, agar, starch, mucopolysaccharide, or a hydrolyzate thereof.
- the cationic product may be in the form of sponge, flake, granule or gel, and these can be used as a padding for pillows or futons. If necessary, the used cationized article can be reused by immersing it in 1% saline, inverted sarcophagus, or a highly basic aqueous solution.
- Cationized products in powder or liquid form are pharmaceuticals, quasi-drugs, cosmetics It can be applied to.
- the cationized polysaccharide or the cationized oligosaccharide is powdered or liquid. More preferably, a cationized polysaccharide or a hydrolyzate thereof such as cellulose, aga, mannan, chitin, inulin, agar, starch, mucopolysaccharide or the like is powdered or liquid. Specific examples include celestial pollen (baby powder), sprays, lotions, liniments, ointments, creams, poultices, patches, packs, and foundations. It may be used as a bath salt.
- reduction of symptoms may be the main effect, and by adding a powdered or liquid cationized polymer, an effect of reducing the symptoms can be added to the original efficacy / effect.
- an effect of reducing the symptoms can be added to the original efficacy / effect.
- Example 1 Example 1
- Sweat antigen adsorption test with cationized fibers (Evaluation by histamine release test) 0.5 g of cationized fibers obtained by treating granular cellulose with Cationone-UK manufactured by Yushi Kogyo Co., Ltd.
- the column was packed and washed with 10 mL of phosphate buffer (PBS). After the washing liquid flowed down to the surface filled with the cationized fiber, the outlet of the column was closed, and 0.3 mL of human sweat was added to the column. After allowing the sweat to permeate into the fiber for 10 minutes, it was eluted with PBS until the total eluate was 3 mL. The protein concentration and histamine release activity of this eluate were measured.
- PBS phosphate buffer
- human sweat was diluted 10-fold with PBS, 2 mL of this was added to 0.33 g of cationized fiber, and the mixture was adsorbed by shaking for 1 hour in a test tube. This was centrifuged at 2,000 rpm for 5 minutes to collect the supernatant, and the protein concentration and histamine release activity in the supernatant were measured. As a result, the antigenic activity in sweat was efficiently absorbed and removed by the cationized fiber. (table
- Sweat antigen adsorption test with cationized fibers evaluation by intradermal reaction test
- 2 mL and 0.3 g of the cationized fiber were placed in a test tube at room temperature 1 Shake for hours.
- non-force thiolated fiber was used.
- the supernatant was sterilized through a 0.22 ⁇ filter and then subjected to an intradermal reaction test using the skin of the subject (sweat donor).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2004/014542 WO2006035508A1 (ja) | 2004-09-27 | 2004-09-27 | アトピー性皮膚炎を軽減または予防する物品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2004/014542 WO2006035508A1 (ja) | 2004-09-27 | 2004-09-27 | アトピー性皮膚炎を軽減または予防する物品 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006035508A1 true WO2006035508A1 (ja) | 2006-04-06 |
Family
ID=36118660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/014542 WO2006035508A1 (ja) | 2004-09-27 | 2004-09-27 | アトピー性皮膚炎を軽減または予防する物品 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006035508A1 (ja) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001303372A (ja) * | 2000-04-26 | 2001-10-31 | Japan Exlan Co Ltd | 抗菌性、抗ウイルス性アクリロニトリル系繊維およびその製造法 |
JP2002293735A (ja) * | 2001-03-29 | 2002-10-09 | Shiseido Co Ltd | 皮膚外用剤 |
JP2003105674A (ja) * | 2001-09-28 | 2003-04-09 | Nicca Chemical Co Ltd | 抗菌性繊維製品の製造方法及び繊維用抗菌剤組成物 |
JP2003160414A (ja) * | 2001-07-26 | 2003-06-03 | Sanyo Chem Ind Ltd | 抗菌剤 |
-
2004
- 2004-09-27 WO PCT/JP2004/014542 patent/WO2006035508A1/ja active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001303372A (ja) * | 2000-04-26 | 2001-10-31 | Japan Exlan Co Ltd | 抗菌性、抗ウイルス性アクリロニトリル系繊維およびその製造法 |
JP2002293735A (ja) * | 2001-03-29 | 2002-10-09 | Shiseido Co Ltd | 皮膚外用剤 |
JP2003160414A (ja) * | 2001-07-26 | 2003-06-03 | Sanyo Chem Ind Ltd | 抗菌剤 |
JP2003105674A (ja) * | 2001-09-28 | 2003-04-09 | Nicca Chemical Co Ltd | 抗菌性繊維製品の製造方法及び繊維用抗菌剤組成物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Radu et al. | Applications of cyclodextrins in medical textiles | |
CN102099015B (zh) | 释放活性成分的制品 | |
CN106456569A (zh) | 用于递送护肤组合物的装置 | |
TW469127B (en) | Absorbent article | |
JPS63501689A (ja) | 液体吸収組成物の製造方法 | |
CN105727346A (zh) | 一种止血织物及其制备方法与应用 | |
BRPI0609129A2 (pt) | composto técnico de multicamadas, recursos médicos ou peças de roupa e uso do composto | |
CN109310797A (zh) | 制备包含纳米原纤纤维素的医疗产品的方法和医疗产品 | |
CN100384485C (zh) | 处理慢性创伤的微生物纤维素创伤敷料 | |
WO2006035508A1 (ja) | アトピー性皮膚炎を軽減または予防する物品 | |
US3804949A (en) | Process of promoting healing of wounds | |
Chandrasekaran et al. | Analysis of eco-friendly medicinal herb extracts and essential oil applications on textile products for healthcare applications | |
JP2005082932A (ja) | アトピー性皮膚炎を軽減または予防する物品 | |
CN102558740B (zh) | 一种用于体育领域中的功能护具材料及其制备方法 | |
RU2596452C1 (ru) | Способ производства текстильного материала, содержащего нано- и микрокапсулированные биологически активные вещества с замедленным высвобождением (варианты) | |
CN108815557A (zh) | 一种具有杀菌消炎止痛功能的卫生巾及其制作方法 | |
Shanmugasundaram et al. | Study of bamboo and cotton blended baby diapers | |
Brănișteanu et al. | Use of textile biomaterials for the topic treatment of chronic venous disease | |
CN212357803U (zh) | 一种卫生用品抗菌防护材料 | |
CN114366448A (zh) | 一种抗菌吸收性物品及其制备方法 | |
CN105708727A (zh) | 一种保湿美白祛斑除痘抑菌敷料及其制备方法 | |
CN101543640A (zh) | 一种可吸收、防粘连止血粉产品及其制备方法 | |
CN110448544A (zh) | 具有抗菌性能的全氟化碳携氧微球及其制备方法和应用 | |
KR20040045192A (ko) | 피부질환을 완화시켜 주는 원단 | |
CN102558648B (zh) | 一种用于体育用品中的功能护具材料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 04773571 Country of ref document: EP Kind code of ref document: A1 |